ERK2 Protein

ERK2 (Extracellular Signal-Regulated Kinase 2)

Overview

ERK2 (Extracellular Signal-Regulated Kinase 2)

Overview

ERK2 (Extracellular Signal-Regulated Kinase 2), also known as MAPK1 (Mitogen-Activated Protein Kinase 1) or p42 MAP Kinase, is a serine/threonine protein kinase that serves as a central mediator of intracellular signal transduction. As the second major isoform in the MAPK/ERK cascade, ERK2 plays essential roles in regulating cell proliferation, differentiation, survival, apoptosis, and synaptic plasticity [1](https://pubmed.ncbi.nlm.nih.gov/10823812/). While closely related to ERK1, ERK2 has distinct and non-redundant functions, with ERK2 knockout being embryonic lethal in mice, highlighting its critical importance [2](https://pubmed.ncbi.nlm.nih.gov/8622653/). [@johnson2002]

ERK2 is ubiquitously expressed and responds to a wide variety of extracellular stimuli including growth factors, neurotransmitters, hormones, and stress. In the brain, ERK2 is particularly important for synaptic plasticity, learning, memory, and neuronal development. Dysregulation of ERK2 signaling is implicated in numerous neurological disorders including Alzheimer's disease, Parkinson's disease, and depression [3](https://pubmed.ncbi.nlm.nih.gov/10545168/). [@raman2007]

<div class="infobox infobox-protein"> [@seger1995]
<table> [@kim2010]
<tr><th>Protein Name</th><td>Extracellular Signal-Regulated Kinase 2</td></tr> [@murray2008]
<tr><th>Gene</th><td>[MAPK1](/genes/mapk1)</td></tr> [@subramaniam2010]
<tr><th>UniProt ID</th><td>[P28482](https://www.uniprot.org/uniprot/P28482)</td></tr> [@bandyopadhyay2004]
<tr><th>PDB IDs</th><td>1GOL, 2ERK, 4QTB, 4QTC</td></tr> [@huang2004]
<tr><th>Molecular Weight</th><td>~42 kDa</td></tr> [@orton2005]
<tr><th>Subcellular Localization</th><td>Cytoplasm, nucleus</td></tr> [@roskoski2012]
<tr><th>Protein Family</th><td>MAP kinase family</td></tr>
<tr><th>Expression</th><td>Ubiquitous, highest in brain, heart, lung</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">158 edges</a></td>
</tr>
</table>
</div>

Structure and Catalytic Properties

Domain Architecture

ERK2 contains the canonical MAP kinase fold with distinct functional regions [4](https://pubmed.ncbi.nlm.nih.gov/2177855/):

Activation Mechanism

ERK2 is activated through dual phosphorylation by MEK1/2:

• Threonine 185 (T185)
• Tyrosine 187 (Y187)

Crystal Structure

The crystal structure of ERK2 has been solved in both active and inactive conformations, revealing the molecular basis for kinase activation and substrate recognition [5](https://pubmed.ncbi.nlm.nih.gov/7686388/).

Signal Transduction

Upstream Activation

ERK2 is activated by diverse extracellular signals through receptor-mediated pathways:

Receptor tyrosine kinases:

• TrkA, TrkB, TrkC (via Shc/Ras/Raf)
• Epidermal growth factor receptor (EGFR)
• Platelet-derived growth factor receptor (PDGFR)
• Fibroblast growth factor receptor (FGFR)

• Muscarinic acetylcholine receptors
• Metabotropic glutamate receptors (mGluRs)
• Dopamine receptors (D1-D5)
• Serotonin receptors (5-HT1A, 5-HT2)

• Cell adhesion molecules
• Cytokines
• Stress (UV radiation, oxidative stress)
• Neuronal depolarization

The MAPK/ERK Cascade

Growth Factor → RTK → Grb2/Sos → Ras → Raf (MEKKK) → MEK1/2 (MAPKK) → ERK1/2 (MAPK)

This conserved cascade provides signal amplification:

• One activated Ras molecule can activate multiple Raf molecules
• Each MEK can phosphorylate multiple ERK molecules
• Each ERK can phosphorylate numerous substrates

Downstream Targets

Activated ERK2 phosphorylates over 200 known substrates [6](https://pubmed.ncbi.nlm.nih.gov/9857196/):

Transcription factors:

• c-Fos, c-Jun, c-Myc
• Elk-1, Sap-1
• CREB, ATF2
• NF-κB, Mef2

• MSK1/2 (mitogen- and stress-activated kinases)
• p90RSK (ribosomal S6 kinase)
• MNK1/2 (MAPK-interacting kinases)
• MAPKAPK2

• Chromatin proteins (histones)
• RNA polymerase II
• Nuclear pores

• Cytoskeletal proteins (MAP2, Tau)
• Ion channels
• Translation machinery

Normal Physiological Functions

Brain Function

In the nervous system, ERK2 is crucial for [3](https://pubmed.ncbi.nlm.nih.gov/10545168/):

Synaptic plasticity:

• Long-term potentiation (LTP)
• Long-term depression (LTD)
• Spine morphogenesis and maintenance
• AMPA receptor trafficking
• NMDA receptor modulation

• Hippocampal-dependent learning
• Consolidation of various memory types
• Fear conditioning
• Spatial memory

• Neuronal differentiation
• Axonal growth and guidance
• Dendritic arborization
• Synaptogenesis

Cellular Processes

ERK2 regulates numerous cellular functions:

• Cell cycle: G1/S transition, S phase progression
• Cell proliferation: Entry into and progression through cell cycle
• Cell survival: Anti-apoptotic signaling via CREB, Mcl-1
• Differentiation: Neuronal, adipocyte, muscle differentiation
• Metabolism: Insulin signaling, glucose uptake

Non-Neural Functions

• Cardiac function: Cardiac hypertrophy, myocyte survival
• Immune response: T-cell activation, cytokine production
• Skin: Keratinocyte proliferation, wound healing
• Bone: Osteoblast differentiation

Role in Neurodegenerative Diseases

Alzheimer's Disease

ERK2 signaling is significantly altered in Alzheimer's disease [7](https://pubmed.ncbi.nlm.nih.gov/11881780/):

Pathological changes:

• Aβ oligomers trigger ERK1/2 activation
• Hyperphosphorylated tau affects ERK2 localization
• Altered ERK2 activity in AD brain regions

• Links Aβ to downstream tau pathology
• Modulates APP processing
• Affects synaptic plasticity deficits

• MEK/ERK inhibitors under investigation
• Context-dependent effects complicate targeting

Parkinson's Disease

ERK2 in Parkinson's disease [8](https://pubmed.ncbi.nlm.nih.gov/17434523/):

• Activated in dopaminergic neurons following MPTP/6-OHDA
• Dual role in survival and death
• α-Synuclein influences ERK2 signaling
• Potential neuroprotective strategies

Huntington's Disease

ERK2 signaling in Huntington's disease [9](https://pubmed.ncbi.nlm.nih.gov/18986545/):

• Mutant huntingtin disrupts ERK2 nuclear signaling
• Impaired transcription regulation
• Interaction with BDNF/TrkB signaling
• Therapeutic targeting potential

Stroke and Ischemia

ERK2 activation in cerebral ischemia:

• Rapid activation within minutes
• Contributes to both injury and repair
• Inflammatory response modulation
• Potential therapeutic window

Depression and Anxiety

ERK2 in mood disorders:

• Reduced ERK2 signaling in depression
• antidepressants can activate ERK2
• Role in neurogenesis
• Memory and emotional processing

Therapeutic Targeting

Challenges

Targeting ERK2 therapeutically is complex:

• Essential functions: ERK2 knockout is embryonic lethal
• Redundancy: Partial overlap with ERK1
• Context-specific: Both protective and pathological roles
• Systemic effects: Ubiquitous expression

Current Approaches

| Approach | Agent/Mechanism | Stage | Notes |
|----------|-----------------|-------|-------|
| MEK inhibitors | Trametinib, Cobimetinib | FDA approved (cancer) | Prevent ERK activation |
| ERK inhibitors | SCH772984 | Preclinical | Direct ERK1/2 inhibition |
| Modulators | Various compounds | Research | Context-specific targeting |

Clinical Applications

Oncology:

• MEK inhibitors for BRAF-mutant melanoma
• KRAS-mutant cancers
• Thyroid cancer

• Cognitive enhancement strategies
• Neuroprotection approaches
• Antidepressant effects

Genetics and Expression

MAPK1 Gene

The MAPK1 gene is located on chromosome 22q11.21 and consists of 10 exons.

Polymorphisms:

• Various SNPs associated with:
• Cognitive function
• Cancer susceptibility
• Psychiatric disorders
• Response to treatment

Expression Patterns

ERK2 is ubiquitously expressed:

• Brain: High in cortex, hippocampus, cerebellum
• Heart: Cardiac myocytes
• Lung: Epithelial cells
• Immune system: T cells, B cells

Research Tools

Genetic Models

• ERK2 knockout mice (embryonic lethal at day 6.5)
• ERK1/ERK2 conditional double knockouts
• Phospho-mutant mice (T185A, Y187F)
• Reporter mice for ERK activity

Chemical Inhibitors

• U0126: MEK1/2 inhibitor (prevents ERK activation)
• PD98059: MEK1/2 inhibitor
• SCH772984: Selective ERK1/2 inhibitor
• VX-11e: ERK2 inhibitor

Antibodies

• Total ERK1/2 antibodies
• Phospho-ERK1/2 (T185/Y187) antibodies
• Nuclear/cytoplasmic fractionation antibodies

Interaction with Other Pathways

ERK2 interacts with numerous signaling networks:

• PI3K/Akt: Cross-talk,协同 effects
• JNK and p38: Parallel MAP kinase pathways
• cAMP/PKA: Modulation by second messengers
• Calcium signaling: Calmodulin-dependent pathways
• Notch signaling: Integration with developmental pathways

ERK2 vs ERK1

While structurally similar, ERK1 and ERK2 have distinct functions [2](https://pubmed.ncbi.nlm.nih.gov/8622653/):

| Feature | ERK2 | ERK1 |
|---------|------|------|
| Size | 42 kDa | 44 kDa |
| Phosphorylation sites | T185, Y187 | T202, Y204 |
| Expression | Higher overall | Lower overall |
| Knockout phenotype | Embryonic lethal | Viable, mild phenotype |
| Substrate specificity | Some unique targets | Some unique targets |

Biomarkers

Clinical Relevance

• Phospho-ERK2: Pathway activation marker
• Nuclear phospho-ERK2: Transcription activation
• Total ERK2: Expression levels

Conclusion

ERK2 is a pivotal kinase in cellular signal transduction with critical roles in normal brain function and neurodegenerative disease pathogenesis. Its essential nature is highlighted by the embryonic lethal phenotype of ERK2 knockout mice. While therapeutic targeting of ERK2 is complicated by its ubiquitous expression and dual roles, ongoing research continues to identify context-specific vulnerabilities that may be exploited for treating neurological disorders. Understanding the precise roles of ERK2 in different cellular contexts remains an important area of investigation.

See Also

• MAPK1 Gene
• [ERK1 Protein](/proteins/erk1-protein)
• [MAPK Signaling Pathway](/mechanisms/mapk-signaling-pathway)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [TrkB Protein](/proteins/trkb-protein)

External Links

• [UniProt: ERK2](https://www.uniprot.org/uniprot/P28482)
• [PDB: ERK2](https://www.rcsb.org/structure/1GOL)
• [PhosphoSitePlus: ERK2](https://www.phosphosite.org/proteinAction.action?id=8724)
• [Human Protein Atlas: MAPK1](https://www.proteinatlas.org/ENSG00000100030-MAPK1)
• [KEGG: MAPK signaling pathway](https://www.genome.jp/kegg/pathway/map/map04010)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ERK2 Protein discovered through SciDEX knowledge graph analysis: